Grape Exosome-Like Nanovesicles Reverse the Prediabetic State in Mice

Area of Science:

• Biochemistry
• Metabolomics
• Microbiome research

Background:

• Prediabetes is a growing health concern characterized by impaired glucose metabolism.
• Gut microbiota dysbiosis is increasingly linked to metabolic disorders like prediabetes.
• Exosome-like nanovesicles are emerging as potential therapeutic agents.

Purpose of the Study:

• To investigate the efficacy of grape exosome-like nanovesicles (GELNs) in reversing prediabetic states in a mouse model.
• To elucidate the underlying mechanisms, including metabolic and gut microbiota alterations, influenced by GELNs.

Main Methods:

• C57BL/6J mice were allocated to normal control, prediabetic model, GELN intervention, and nutrient intervention groups.
• Prediabetes was induced, followed by an 8-week intervention period.
• Metabolomic analysis and 16S rDNA sequencing were employed to assess metabolic and microbial changes.

Main Results:

• GELNs significantly ameliorated fasting blood glucose, postprandial glucose, insulin levels, and total cholesterol.
• Metabolomic profiling revealed alterations in tryptophan and riboflavin metabolism.
• Significant shifts in gut microbiota composition were observed, including changes in phylum-level abundance and a reduction in Akkermansia at the genus level.

Conclusions:

• Grape exosome-like nanovesicles demonstrate potential in reversing prediabetes by enhancing metabolic parameters and restoring gut homeostasis.
• These findings provide novel insights into the therapeutic application of GELNs for prediabetes management.